Katherine E. Hutchinson

4.6k citations

48 papers · 1.8k indexed · 1 hit paper · h-index 19

Cancer Research top 5%
- Cancer Genomics and Diagnostics 9
Oncology top 5%
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 7
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
Pulmonary and Respiratory Medicine top 5%
- Advanced Breast Cancer Therapies 13
- Lung Cancer Treatments and Mutations 9
Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 6
Neurology
- Neuroblastoma Research and Treatments 7

Co-authors: William Pao Carlos L. Arteaga Violeta Sánchez Mónica V. Estrada Melinda E. Sanders Kyung‐min Lee Justin M. Balko Ángel Guerrero‐Zotano
Cited by: Cancer Research Oncology Genetics
Journals: Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Journal of Clinical Investigation (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Katherine E. Hutchinson

48 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Katherine E. Hutchinson

Since Specialization

Citations

This map shows the geographic impact of Katherine E. Hutchinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Hutchinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Hutchinson more than expected).

Fields of papers citing papers by Katherine E. Hutchinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Hutchinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Hutchinson. The network helps show where Katherine E. Hutchinson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katherine E. Hutchinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katherine E. Hutchinson Line = papers co-authored together Katherine E. Hutchinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077) Molecular Cancer Therapeutics ·K S Song,Christy C. Ong,Eva Lin,Jeff Lau,Nicole M. Sodir,Dexter X. Jin,Katherine E. Hutchinson,Shiqi Xie,Jenille Tan,Yuxin Liang,Zora Modrušan,Scott E. Martin,Danilo Maddalo,Marc Hafner,Anwesha Dey	2025	1
2	Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions European Journal of Cancer ·Ami V. Desai,Aditi Bagchi,Amy E. Armstrong,Cornelis M. van Tilburg,Ellen M. Basu,Giles Robinson,Huanmin Wang,Michela Casanova,Nicolás André,Quentin Campbell-Hewson,Yeming Wu,Alison K. Cardenas,Bo Ci,Carolina Ryklansky,Clare Devlin,Georgina Meneses‐Lorente,Jade Wulff,Katherine E. Hutchinson,Amar Gajjar,Elizabeth Fox	2025	1
3	ER +, HER2 − advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes Molecular Oncology ·Jessica W. Chen,William Jacot,Javier Cortés,Ian E. Krop,Susan Dent,Nadia Harbeck,Michelino De Laurentiis,Véronique Dièras,Young‐Hyuck Im,Thomas J. Stout,Frauke Schimmöller,Heidi Savage,Katherine E. Hutchinson,Timothy R. Wilson	2023	1
4	Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations Clinical Cancer Research ·Smruthy Sivakumar,Dexter X. Jin,Ruchita Rathod,Jeffrey S. Ross,Lewis C. Cantley,Maurizio Scaltriti,Jessica W. Chen,Katherine E. Hutchinson,Timothy R. Wilson,Ethan Sokol,Neil Vasan	2023	16
5	Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab Nature Cancer ·Arash Nabbi,Arnavaz Danesh,Osvaldo Espin‐Garcia,Stephanie Pedersen,Johanna Wellum,Lingyan Helen Fu,Joseph N. Paulson,Birgit Geoerger,Lynley V. Marshall,Tanya Trippett,Gianluca Rossato,Trevor J. Pugh,Katherine E. Hutchinson	2023	5
6	Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study Targeted Oncology ·Tanya Trippett,Helen Toledano,Quentin Campbell Hewson,Arnauld Verschuur,Anne‐Marie Langevin,Isabelle Aerts,Lisa Howell,Soledad Gallego,Claudia Rössig,Amy Smith,Darshak Patel,Leonardo Pereira,Sravanthi Cheeti,Luna Musib,Katherine E. Hutchinson,Clare Devlin,Ronald J. Bernardi,Birgit Geoerger	2022	30
7	355TiP Phase III study of GDC-0077 or placebo (pbo) with palbociclib (P) + fulvestrant (F) in patients (pts) with PIK3CA-mutant/hormone receptor-positive/HER2-negative locally advanced or metastatic breast cancer (HR+/HER2– LA/MBC) Annals of Oncology ·Nicholas C. Turner,Komal Jhaveri,Kevin Kalinsky,Sibylle Loibl,Sherene Loi,S-A. Im,Cristina Saura,Peter Schmid,Jennifer L. Schutzman,TJ Stout,Guiyuan Lei,Katherine E. Hutchinson,Eirini Thanopoulou,Dejan Juric	2020	6
8	Abstract 29: Utility of novel clinico-genomic data to understand patient characteristics, treatments, and outcomes according to PIK3CA mutation status among hormone receptor-positive metastatic breast cancer patients Clinical Cancer Research ·Mary K. Downer,Peter Lambert,Sami Mahrus,Katherine E. Hutchinson,Patricia Luhn,Jennifer L. Schutzman	2020	1
9	Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study The Lancet Oncology ·Birgit Geoerger,C. Michel Zwaan,Lynley V. Marshall,Jean Michon,Franck Bourdeaut,Michela Casanova,Nadège Corradini,Gianluca Rossato,Mufiza Farid‐Kapadia,Colby S. Shemesh,Katherine E. Hutchinson,Francis Donaldson,Minlei Liao,Hubert Caron,Tanya Trippett	2019	105
10	Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer Cancer Research ·Valerie M. Jansen,Neil E. Bhola,Joshua A. Bauer,Luigi Formisano,Kyung‐min Lee,Katherine E. Hutchinson,Agnieszka K. Witkiewicz,Preston D. Moore,Mónica V. Estrada,Violeta Sánchez,Paula I. González-Ericsson,Melinda E. Sanders,Paula R. Pohlmann,Michael J. Pishvaian,David A. Riddle,Teresa C. Dugger,Wenyi Wei,Erik S. Knudsen,Carlos L. Arteaga	2017	171
11	An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression JNCI Journal of the National Cancer Institute ·Luis J. Schwarz,Katherine E. Hutchinson,Brent N. Rexer,Mónica V. Estrada,Paula I. González-Ericsson,Melinda E. Sanders,Teresa C. Dugger,Luigi Formisano,Ángel Guerrero‐Zotano,Monica Red-Brewer,Christian D. Young,Johan Lantto,Mikkel W. Pedersen,Michael Kragh,Ivan D. Horak,Carlos L. Arteaga	2017	35
12	Optimizing the Sequence of Anti-EGFR–Targeted Therapy in EGFR-Mutant Lung Cancer Molecular Cancer Therapeutics ·Catherine B. Meador,Hailing Jin,Elisa de Stanchina,Caroline A. Nebhan,Valentina Pirazzoli,Lu Wang,Huy Gia Vuong,Katherine E. Hutchinson,Peilin Jia,Xi Chen,Rosana Eisenberg,Marc Ladanyi,Katerina Politi,Zhongming Zhao,Christine M. Lovly,Darren A.E. Cross,William Pao	2014	22
13	A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance Molecular Cancer Therapeutics ·Junfeng Xia,Peilin Jia,Katherine E. Hutchinson,Kimberly B. Dahlman,Douglas B. Johnson,Jeffrey A. Sosman,William Pao,Zhongming Zhao	2014	65
14	Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent RAF Fusions and Frequent Inactivation of DNA Repair Genes Cancer Discovery ·Juliann Chmielecki,Katherine E. Hutchinson,Garrett M. Frampton,Zachary R. Chalmers,Adrienne Johnson,Chanjuan Shi,Julia A. Elvin,Siraj M. Ali,Jeffrey S. Ross,Olca Baştürk,Sohail Balasubramanian,Doron Lipson,Roman Yelensky,William Pao,Vincent A. Miller,David S. Klimstra,Philip J. Stephens	2014	126
15	Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome) Annals of Oncology ·Reinhard Dummer,Madeleine Duvic,Julia Scarisbrick,Elise A. Olsen,Sima Rozati,N. Eggmann,Simone M. Goldinger,Katherine E. Hutchinson,Larisa J. Geskin,Tim Illidge,Enzo Giuliano,J B Elder,Y.H. Kim	2014	36
16	BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition Clinical Cancer Research ·Katherine E. Hutchinson,Doron Lipson,Philip J. Stephens,Geoff Otto,Brian D. Lehmann,Pamela L. Lyle,Cindy L. Vnencak‐Jones,Jeffrey S. Ross,Jennifer A. Pietenpol,Jeffrey A. Sosman,Igor Puzanov,Vincent A. Miller,William Pao	2013	124
17	Calcium Signaling Inhibitors Reduce Retinal Cell Responses to High Glucose Investigative Ophthalmology & Visual Science ·Colin A. Bretz,Gillian Treadwell,Katherine E. Hutchinson,John S. Penn	2011	1
18	EGFR-Mutant Lung Adenocarcinomas Treated First-Line with the Novel EGFR Inhibitor, XL647, Can Subsequently Retain Moderate Sensitivity to Erlotinib Journal of Thoracic Oncology ·Juliann Chmielecki,M. Catherine Pietanza,Dana T. Aftab,Ronglai Shen,Zhiguo Zhao,Xi Chen,Katherine E. Hutchinson,Agnès Viale,Mark G. Kris,Thomas J. Stout,Vincent A. Miller,Naiyer A. Rizvi,William Pao	2011	17
19	A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer Journal of Molecular Diagnostics ·Zengliu Su,Dora Dias‐Santagata,MarKeesa Duke,Katherine E. Hutchinson,Ya-Lun Lin,Darrell R. Borger,Christine H. Chung,Pierre P. Massion,Cindy L. Vnencak‐Jones,A. John Iafrate,William Pao	2011	138
20	Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer Nucleic Acids Research ·Juliann Chmielecki,Martin Peifer,Peilin Jia,Nicholas D. Socci,Katherine E. Hutchinson,Agnès Viale,Zhongming Zhao,Roman K. Thomas,William Pao	2010	35

About Katherine E. Hutchinson

Katherine E. Hutchinson is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (13 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Neuroblastoma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Cancer Research (595 citations), Oncology (920 citations) and Genetics (180 citations). Katherine E. Hutchinson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include William Pao, Carlos L. Arteaga, Violeta Sánchez, Mónica V. Estrada, Melinda E. Sanders, Kyung‐min Lee, Justin M. Balko, Ángel Guerrero‐Zotano, Luis J. Schwarz and Jennifer M. Giltnane. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact